iShares Genomics Immunology and Healthcare ETF (NY:IDNA)

41.76 +0.48 (+1.16%)

Delayed Quote Updated: 10:24 AM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Genomics Immunology and Healthcare ETF

3 ETFs For the Coming Genomics Revolution ↗

June 07, 2026

Genomics companies are an exciting frontier in health care, and ETFs can help to diversify to control risk while positioning investors to benefit.

Via MarketBeat

Topics ETFs

Why Did BNTX Stock Tumble 17% Pre-Market Today? ↗

March 10, 2026

BioNTech co-founders Ugur Sahin and Özlem Türeci are set to leave the company to head the new venture.

Via Stocktwits

IBRX Stock Rises Pre-Market After ANKTIVA Combo Shows Stronger Bladder Cancer Responses In Phase 2 Trial ↗

February 26, 2026

The company said it plans to submit a biologics license application by the fourth quarter of 2026.

Via Stocktwits

Moderna Stock Gains After FDA Accepts Company’s Revised Flu Vaccine Application For Review ↗

February 18, 2026

The FDA has now accepted the biologics license application for review, setting a Prescription Drug User Fee Act goal date of Aug. 5, 2026.

Via Stocktwits

Why Is ALVO Stock Rising Pre-Market Today? ↗

February 05, 2026

The company reported that the study showed AVT80, its biosimilar candidate to Entyvio, met all primary endpoints.

Via Stocktwits

Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal ↗

May 19, 2025

Regeneron (REGN) to acquire 23andMe for $256 million, plans to maintain consumer services and uphold privacy policies. Deal expected to close Q3 2025.

Via Benzinga

Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion ↗

April 28, 2025

Merck & Company, Inc. (MRK) to acquire SpringWorks Therapeutics, Inc. (SWTX) for $47/share in cash, creating synergies for rare tumor treatments and immediate revenue growth.

Via Benzinga

Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm? ↗

January 28, 2025

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health Organization on Monday, marking a dramatic acceleration of President Donald...

Via Benzinga

Topics Government

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies ↗

January 08, 2025

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

Via Benzinga

Topics ETFs

FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch ↗

August 19, 2024

The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.

Via Benzinga

Topics ETFs

Top Thematic ETF Ideas For 2024 ↗

January 24, 2024

With AI adoption and spending expected to expand this year, new avenues for business growth will open up for tech companies beyond the Magnificent Seven.

Via Talk Markets

Topics Artificial Intelligence ETFs

3 Healthcare Technology Stocks to Improve Lives in 2024 ↗

December 25, 2023

Healthcare technology is one of 2024's top investment trends, and investors looking for long-term upside should check out these top stocks.

Via InvestorPlace

Move Over, ChatGPT: 5 Stock Ideas For Leveraging The Power Of AI In Health Care, Cybersecurity ↗

April 04, 2023

Generative artificial intelligence has taken the world by storm in 2023.

Via Benzinga

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗

March 15, 2023

To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.

Via InvestorPlace

7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher ↗

August 17, 2022

These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up.

Via InvestorPlace

ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM ↗

October 21, 2021

The search for therapies tackling chronic illnesses like cancer, diabetes, and heart disease has put stocks in the biotechnology and genomics industry sector on center stage.

Via Talk Markets

Take A Look At The Top-Performing Biotech ETFs YTD ↗

October 02, 2021

The biotechnology sector has been grabbing the headlines on the new coronavirus vaccine and drug-related updates. The space has also kept its promise of generating returns, with the Nasdaq...

Via Talk Markets

A Comprehensive Guide To Genomic ETFs ↗

July 11, 2021

Given the growing applications of gene-editing, it is a rising market which offers endless opportunities. Growing demand for personalized medicine, solid investments and higher R&D activities will soon...

Via Talk Markets

Moderna ETFs To Rise On Positive COVID-19 Vaccine Updates ↗

July 03, 2021

The competition to come up with a vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to...

Via Talk Markets

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.